The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. filed Form 8.3 with the Irish Takeover Panel regarding its position in Mural Oncology plc. As of August 22, 2025, Vanguard controls 771,571 ordinary shares, which represents a 4.47% interest in Mural Oncology. This disclosure follows the rules set by the Irish Takeover Panel Act of 1997.

No short positions are held by Vanguard in the relevant securities, and no cash-settled or stock-settled derivatives are reported. Recent transactions include the purchase of 32 and the sale of 128 ordinary shares at a price of 2.08 USD per unit.

There are no indemnity agreements, options, or other arrangements in place that would affect Vanguard's dealings with Mural Oncology securities. Vanguard has not engaged in any agreements affecting voting rights or future acquisition or disposal of securities.